Is Hims & Hers Health Stock in Trouble?
In the past 12 months, the stock has nosedived more than 50%.
Overview
Hims & Hers Health (NYSE: HIMS) has been a hot growth stock to own in recent years. In 2024, it surged by 172%, and in 2025, it finished the year up 34%. But it's been struggling of late and is down significantly from its highs.
Recently, there's also been troubling news with the Federal Trade Commission (FTC) alleging that the telehealth company shared customer health information without consent. Things appear to be going from bad to worse for Hims & Hers Health. Is now the time to dump the stock, or could it be a good time to buy while its value is so low?
Image source: Getty Images.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.